Daily News Podcast

Updated anthrax vaccine recommendations

Publish date: July 2, 2018

 

The advisory committee on Immunization Practices voted to approve recommendations for the use of Anthrax Vaccine Adsorbed (AVA) in post-exposure prophylaxis (PEP) in the event of a wide-area release of Bacillus anthracis spores. Also today, the FDA approves topical anticholinergic for primary axillary hyperhidrosis, a shortage of ob.gyns. looms, and more Americans missed care in 2017 as a result of cost.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Dermatology
JAK inhibitor therapy promising for refractory dermatomyositis
MDedge Dermatology
Patients going without as insulin prices skyrocket
MDedge Dermatology
Chilblain Lupus Erythematosus Presenting With Bilateral Hemorrhagic Bullae of Distal Halluces
MDedge Dermatology
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Dermatology
Opioids do more harm than good for musculoskeletal pain
MDedge Dermatology
Adalimumab strikes out for aortic inflammation in psoriasis
MDedge Dermatology
Addiction: Veterans with pain, opioid use disorder
MDedge Dermatology
Anthrax vaccine recommendations updated in the event of a wide-area release
MDedge Dermatology
Medicare beneficiaries are dying differently
MDedge Dermatology